Sterile 0.9% (w/v) sodium chloride solution in single-use PFS
Sponsors
Glaxosmithkline Research & Development Limited
Conditions
Chronic Obstructive Pulmonary Disease
Phase 3
A randomized, double-blind, placebo-controlled, parallel-group, multicenter study of the efficacy and safety of depemokimab in adult participants with COPD with Type 2 inflammation
RecruitingCTIS2024-520417-41-00
Start: 2026-01-07Target: 327Updated: 2026-01-20
A randomized, double-blind, placebo-controlled, parallel-group, multicenter study of the efficacy and safety of depemokimab in adult participants with COPD with Type 2 inflammation.
RecruitingCTIS2024-520418-22-00
Start: 2026-01-20Target: 453Updated: 2026-01-09